COMMENTARY - US Pharmacopeial Convention
COMMENTARY - US Pharmacopeial Convention
COMMENTARY - US Pharmacopeial Convention
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
General Chapters<br />
General Chapter/Section(s): Injections/Ingredients<br />
Expert Committee(s): Excipient Monographs 2/General Chapters–Parenteral<br />
Products Industrial<br />
No. of Commenters: 3<br />
Comment Summary #1: The commenters suggested three changes to Aqueous<br />
vehicles: 1) use the Coulometric Karl Fisher titration method, which is more suitable for<br />
determination of low water contents, 2) allow the use of commercial Karl Fisher<br />
Reagents, and 3) remove chloroform due to its toxicity.<br />
Response: Comments incorporated. The Expert Committee revised the Water method<br />
from Method Ia to Method Ic (Coulometric Karl Fisher titration) and deleted a proposed<br />
solvent.<br />
Comment Summary #2: In the Limit of copper, iron, lead, and nickel test, a commenter<br />
indicated that metal catalysts are not used in unhydrogenated oils manufacturing and<br />
therefore nickel is not likely to be an impurity.<br />
Response: Comment incorporated. The Expert Committee clarified the impurities<br />
requirements by adding a Note to the Limit of copper, iron, lead and nickel test.<br />
General Chapter/Section(s): Test for 1,6-Anhydro Derivative for Enoxaparin<br />
Sodium/Multiple Sections<br />
Expert Committee(s): Biologics and Biotechnology–Blood and Blood Products<br />
No. of Commenters: 3<br />
Comment Summary #1: The commenters indicated that the equation provided to<br />
calculate the mole percent of components containing a 1,6-anhydro structure is not<br />
correct.<br />
Response: Correction incorporated.<br />
Comment Summary #2: The commenter indicated the assumption is not accurate that<br />
all species observed in the chromatogram have an equivalent response factor.<br />
Response: Comment not incorporated because the assumption is based on an<br />
equivalent molar response factor.<br />
Comment Summary #3: The commenters suggested adding a chromatogram with<br />
annotation.<br />
Response: Comment incorporated. A reference chromatogram will be provided with the<br />
instructions for use of the relevant <strong>US</strong>P Reference Standards.<br />
Comment Summary #4: The commenters suggested adding the following additional<br />
Reference Standards: 1) a control Enoxaparin Reference Standard that can be digested<br />
and chromatographed as part of system suitability, and 2) a disaccharide solution<br />
containing the ΔIS 1,6-anhydro and the ΔIS-IS 1,6-anhydro compounds.<br />
Response: Comment incorporated to include the control Enoxaparin Sodium Reference<br />
Standard (RS). The disaccharide compounds are commercially available as reagents.<br />
Comment Summary #5: The commenter suggested that the depolymerization<br />
suitability specification was not met.<br />
Response: Comment not incorporated because submitted results were obtained on the<br />
formulated drug product. The results clearly indicate an incomplete depolymerization. It<br />
- 3 -